Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Macrothrombocytopenia with mitral valve insufficiency is a rare hemorrhagic disorder due to a platelet anomaly characterized by dysfunctional platelets of abnormally large size, moderate thrombocytopenia, prolonged bleeding time and mild bleeding diathesis (ecchymoses and epistaxis), associated with mitral valve insufficiency.
Biomarker and diagnostic research for marcothrombocytopenia with mitral valve insufficiency has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for marcothrombocytopenia with mitral valve insufficiency.
200 publications have been identified in PubMed for marcothrombocytopenia with mitral valve insufficiency. Kisho has analyzed 88 by research type. Research spans Clinical Trial Publication (32%), Review / Meta-Analysis (26%), and Other (19%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 28 | 32% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
23 |
26% |
Other research | 17 | 19% |
Disease patterns and progression | 11 | 13% |
Patient case studies | 6 | 7% |
Laboratory research | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Ruberti A (2026). [PMID: 41711021](https://pubmed.ncbi.nlm.nih.gov/41711021/). *Circ Cardiovasc Interv*. [Review / Meta-Analysis]
Neema PK (2026). [PMID: 41543403](https://pubmed.ncbi.nlm.nih.gov/41543403/). *Ann Card Anaesth*. [Review / Meta-Analysis]
Groshenry N (2026). [PMID: 41605563](https://pubmed.ncbi.nlm.nih.gov/41605563/). *JACC Cardiovasc Interv*. [Clinical Trial Publication]
Scoma CB (2026). [PMID: 41242772](https://pubmed.ncbi.nlm.nih.gov/41242772/). *Cardiol Clin*. [Review / Meta-Analysis]
Malahfji M (2026). [PMID: 41175121](https://pubmed.ncbi.nlm.nih.gov/41175121/). *JACC Cardiovasc Imaging*. [Epidemiology / Natural History]
Hausleiter S (2026). [PMID: 41609859](https://pubmed.ncbi.nlm.nih.gov/41609859/). *Eur Heart J Cardiovasc Imaging*. [Clinical Trial Publication]
Matsumoto S (2026). [PMID: 41518359](https://pubmed.ncbi.nlm.nih.gov/41518359/). *JACC Cardiovasc Interv*. [Epidemiology / Natural History]
Kainuma S (2026). [PMID: 41580071](https://pubmed.ncbi.nlm.nih.gov/41580071/). *J Thorac Cardiovasc Surg*. [Clinical Trial Publication]
Ahmed F (2026). [PMID: 41667188](https://pubmed.ncbi.nlm.nih.gov/41667188/). *Open Heart*. [Clinical Trial Publication]
Ruf TF (2026). [PMID: 42084643](https://pubmed.ncbi.nlm.nih.gov/42084643/). *Herz*. [Clinical Trial Publication]